Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium and Valproate in ALS
NCT03204500Phase 2Completed
- Sponsor
- National Institute of Neurology and Neurosurgery
- Start
- May 2016
- Primary completion
- Apr 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate, magnesium valproate in amyotrophic lateral sclerosis (ALS), sponsored by National Institute of Neurology and Neurosurgery. Started May 2016; status: completed.
02
Drugs
lithium carbonatemagnesium valproate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03204500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204500.